Tejada MÁ

No ORCID on file · 3 papers in corpus
other 2025
Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1546059
meta-analysis 2024
P2X3 and P2X2/3 receptors inhibition produces a consistent analgesic efficacy: A systematic review and meta-analysis of preclinical studies
European journal of pharmacology ·doi:10.1016/j.ejphar.2024.177052

BACKGROUND: P2X3 and P2X2/3 receptors are promising therapeutic targets for pain treatment and selective inhibitors are under evaluation in ongoing clinical trials. Here we aim to consolidate and quantitatively evaluate the preclinical evid…

lab-animal 2021
A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment
Biomedicines ·doi:10.3390/biomedicines9030269

Dopamine receptor 2 agonists (D2-ags) have been shown to reduce the size of tumors by targeting aberrant angiogenesis in pathological tissue. Because of this, the use of a D2-ag was inferred for endometriosis treatment. When assayed in mous…